Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticotropin for the Treatment of Behçet's Disease
NCT07833163Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of repository corticotropin injection in Behçet's disease (BD), sponsored by Peking University People's Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
repository corticotropin injection
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on NCT07833163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07833163.